Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_36944 | 22 | 0.45 | Mlig455_065298, Mlig455_065320 | Neo: - Age: Up-Down-Up |
NR2F1 | Mlig455_065298 {REF} {Length: 2485} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=100.7]; Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=95.1]} {Human: ENSG00000175745, NR2F1, nuclear receptor subfamily 2 group F member 1, [RH, Score=241, Expect=4e-73]; ENSG00000185551, NR2F2, nuclear receptor subfamily 2 group F member 2, [RH, Score=240, Expect=2e-72]} {Mouse: ENSMUSG00000069171, Nr2f1, nuclear receptor subfamily 2, group F, member 1, [RH, Score=240, Expect=2e-72]; ENSMUSG00000030551, Nr2f2, nuclear receptor subfamily 2, group F, member 2, [RH, Score=240, Expect=1e-72]} {Dmel: FBgn0003651, svp, seven up, [RH, Score=240, Expect=3e-71]} {Celegans: WBGene00006790, unc-55, UNC-55b isoform, [RH, Score=150, Expect=4e-40]} {Smed: dd_Smed_v6_33286_0_1, dd_Smed_v6_33286_0_1, [RH, Score=211, Expect=4e-61]} Mlig455_065320 {REF} {Length: 3080} {Pfam: Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=76.1]} {Human: ENSG00000175745, NR2F1, nuclear receptor subfamily 2 group F member 1, [Score=215, Expect=6e-67]; ENSG00000185551, NR2F2, nuclear receptor subfamily 2 group F member 2, [Score=214, Expect=5e-66]} {Mouse: ENSMUSG00000069171, Nr2f1, nuclear receptor subfamily 2, group F, member 1, [Score=215, Expect=2e-68]; ENSMUSG00000030551, Nr2f2, nuclear receptor subfamily 2, group F, member 2, [Score=214, Expect=4e-66]} {Dmel: FBgn0003651, svp, seven up, [Score=211, Expect=2e-66]} {Celegans: WBGene00006790, unc-55, UNC-55b isoform, [Score=69.3, Expect=4e-13]} {Smed: dd_Smed_v6_33286_0_1, dd_Smed_v6_33286_0_1, [Score=183, Expect=9e-54]} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | 3.95 | 0.944 | 0.99998 | 1.00000 | |
RegionR2 | 1.505 | 0.944 | 0.92331 | 1.00000 | |
RegionR3 | 0.747 | 0.944 | 0.61276 | 1.00000 | |
RegionR4 | 1.871 | 0.944 | 0.99984 | 1.00000 | |
RegionR5 | -1.6 | 0.944 | 0.95756 | 1.00000 | |
RegionR6 | -2.509 | 0.944 | 0.99981 | 1.00000 | |
RegionR7 | -1.993 | 0.944 | 0.99981 | 1.00000 | |
RegionR8 | -1.971 | 0.944 | 0.99979 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -3.785 | 0.944 | 0.99994 | 1.00000 | |
RegenerationR2 | -0.336 | 0.944 | 0.94592 | 1.00000 | |
RegenerationR3 | -0.064 | 0.944 | 0.27254 | 0.70691 | |
RegenerationR4 | 0.588 | 0.944 | 0.83750 | 1.00000 | |
RegenerationR5 | 0.762 | 0.944 | 0.85796 | 1.00000 | |
RegenerationR6 | -0.617 | 0.944 | 0.99993 | 1.00000 | |
RegenerationBL | 0.095 | 0.944 | 1.00000 | 1.00000 | |
RegenerationTP | 2.467 | 0.944 | 0.79713 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_36944 | 22 | 0.45 | Mlig455_065298, Mlig455_065320 | Neo: - Age: Up-Down-Up |
NR2F1 | 5 | 1.000 | - | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_065298 {REF} {Length: 2485} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=100.7]; Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=95.1]} {Human: ENSG00000175745, NR2F1, nuclear receptor subfamily 2 group F member 1, [RH, Score=241, Expect=4e-73]; ENSG00000185551, NR2F2, nuclear receptor subfamily 2 group F member 2, [RH, Score=240, Expect=2e-72]} {Mouse: ENSMUSG00000069171, Nr2f1, nuclear receptor subfamily 2, group F, member 1, [RH, Score=240, Expect=2e-72]; ENSMUSG00000030551, Nr2f2, nuclear receptor subfamily 2, group F, member 2, [RH, Score=240, Expect=1e-72]} {Dmel: FBgn0003651, svp, seven up, [RH, Score=240, Expect=3e-71]} {Celegans: WBGene00006790, unc-55, UNC-55b isoform, [RH, Score=150, Expect=4e-40]} {Smed: dd_Smed_v6_33286_0_1, dd_Smed_v6_33286_0_1, [RH, Score=211, Expect=4e-61]} Mlig455_065320 {REF} {Length: 3080} {Pfam: Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=76.1]} {Human: ENSG00000175745, NR2F1, nuclear receptor subfamily 2 group F member 1, [Score=215, Expect=6e-67]; ENSG00000185551, NR2F2, nuclear receptor subfamily 2 group F member 2, [Score=214, Expect=5e-66]} {Mouse: ENSMUSG00000069171, Nr2f1, nuclear receptor subfamily 2, group F, member 1, [Score=215, Expect=2e-68]; ENSMUSG00000030551, Nr2f2, nuclear receptor subfamily 2, group F, member 2, [Score=214, Expect=4e-66]} {Dmel: FBgn0003651, svp, seven up, [Score=211, Expect=2e-66]} {Celegans: WBGene00006790, unc-55, UNC-55b isoform, [Score=69.3, Expect=4e-13]} {Smed: dd_Smed_v6_33286_0_1, dd_Smed_v6_33286_0_1, [Score=183, Expect=9e-54]} |
2. | MligTC455_24406 | 204 | 4.25 | Mlig455_043947 | Neo: - Age: - Region-specific R2: 3.852 Region-enriched R2: 3.953/0.00003 |
3.521 | 0.925 | - | 0.958 | 0.913 | 0.725 | - | Mlig455_043947 {REF} {Length: 1609} {RNA1509_54091} {RNA1310_68348.1, RNA1509_54091} {RNA1509_54091, RNA815_33570.1} | |
3. | MligTC455_26690 | 58 | 1.2 | Mlig455_044790 | Neo: - Age: - |
PDE9A | 2.93 | 0.965 | - | 0.993 | 0.972 | - | - | Mlig455_044790 {REF} {Length: 2883} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=286.3]} {Human: ENSG00000160191, PDE9A, phosphodiesterase 9A, [RH, Score=604, Expect=0.0]} {Mouse: ENSMUSG00000041119, Pde9a, phosphodiesterase 9A, [RH, Score=605, Expect=0.0]} {Dmel: FBgn0259171, Pde9, Phosphodiesterase 9, [RH, Score=353, Expect=3e-108]} {Celegans: WBGene00020114, pde-4, Probable 3',5'-cyclic phosphodiesterase pde-4, [Score=186, Expect=5e-52]} {Smed: dd_Smed_v6_13304_0_1, dd_Smed_v6_13304_0_1, [RH, Score=328, Expect=6e-106]} {RNA1310_14017} {RNA815_23817} |
4. | MligTC455_12102 | 59 | 1.23 | Mlig455_041538, Mlig455_053099 | Neo: - Age: - Region-enriched R2: 6.626/0.00371 |
DEGS2 | 2.907 | 0.985 | - | 0.950 | 0.972 | - | - | Mlig455_041538 {REF} {Length: 1966} {Pfam: Fatty acid desaturase [PF00487.26, score=87.9]; Sphingolipid Delta4-desaturase (DES) [PF08557.12, score=57.6]} {Human: ENSG00000168350, DEGS2, delta 4-desaturase, sphingolipid 2, [Score=319, Expect=2e-107]; ENSG00000143753, DEGS1, delta 4-desaturase, sphingolipid 1, [Score=315, Expect=5e-106]} {Mouse: ENSMUSG00000038633, Degs1, delta(4)-desaturase, sphingolipid 1, [Score=308, Expect=2e-103]; ENSMUSG00000021263, Degs2, delta(4)-desaturase, sphingolipid 2, [Score=307, Expect=6e-103]} {Dmel: FBgn0001941, ifc, infertile crescent, [Score=345, Expect=5e-118]} {Celegans: WBGene00017996, F33D4.4, Putative sphingolipid delta(4)-desaturase, [Score=318, Expect=4e-107]} {Smed: dd_Smed_v6_7414_0_1, dd_Smed_v6_7414_0_1, [RH, Score=409, Expect=7e-143]} {RNA1310_20672.2} {RNA815_19986} Mlig455_053099 {REF} {Length: 2009} {Pfam: Fatty acid desaturase [PF00487.26, score=87.9]; Sphingolipid Delta4-desaturase (DES) [PF08557.12, score=57.5]} {Human: ENSG00000168350, DEGS2, delta 4-desaturase, sphingolipid 2, [Score=319, Expect=2e-107]; ENSG00000143753, DEGS1, delta 4-desaturase, sphingolipid 1, [Score=315, Expect=4e-106]} {Mouse: ENSMUSG00000038633, Degs1, delta(4)-desaturase, sphingolipid 1, [Score=309, Expect=7e-104]; ENSMUSG00000021263, Degs2, delta(4)-desaturase, sphingolipid 2, [Score=307, Expect=5e-103]} {Dmel: FBgn0001941, ifc, infertile crescent, [Score=345, Expect=4e-118]} {Celegans: WBGene00017996, F33D4.4, Putative sphingolipid delta(4)-desaturase, [Score=318, Expect=3e-107]} {Smed: dd_Smed_v6_7414_0_1, dd_Smed_v6_7414_0_1, [RH, Score=409, Expect=4e-143]} {RNA1310_20672.1} {RNA815_19986} |
5. | MligTC455_38949 | 105 | 2.19 | Mlig455_065209 | Neo: - Age: - Region-specific R2: 7.633 Region-enriched R2: 10.088/0.00000 |
2.894 | 0.988 | - | 0.998 | 0.908 | - | - | Mlig455_065209 {REF} {Length: 591} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=23.2]} {RNA1509_44618} {RNA1310_63839, RNA1509_44618} {RNA1509_44618, RNA815_35329} | |
6. | MligTC455_47420 | 218 | 4.54 | Mlig455_017159, Mlig455_048110 | Neo: - Age: - Region-specific R2: 6.469 Region-enriched R2: 5.851/0.00135 |
2.879 | 0.963 | - | 0.995 | 0.921 | - | - | Mlig455_017159 {REF} {Length: 1062} {RNA1509_35349} {RNA1310_81586} Mlig455_048110 {REF} {Length: 527} {RNA1310_81586} |
|
7. | MligTC455_17178 | 54 | 1.12 | Mlig455_067758 | Neo: - Age: - Region-enriched R2: 7.471/0.00007 |
2.873 | 0.990 | - | 0.996 | 0.887 | - | - | Mlig455_067758 {REF} {Length: 2301} {RNA1509_44702} {RNA1310_14743} {RNA815_20669.1} | |
8. | MligTC455_17177 | 103 | 2.15 | Mlig455_048992, Mlig455_049009 | Neo: - Age: Down-Down-Up |
2.87 | 0.989 | - | 0.996 | 0.885 | - | - | Mlig455_048992 {REF} {Length: 1836} {RNA1509_44702} {RNA1310_14743, RNA1509_44702} {RNA1509_44702, RNA815_20669.1} Mlig455_049009 {REF} {Length: 1823} {RNA1509_44702} {RNA1310_14743} {RNA815_20669.1} |
|
9. | MligTC455_34525 | 52 | 1.08 | Mlig455_021566 | Neo: - Age: Down-Up-Down |
GNAI1 | 2.87 | 0.988 | - | 0.982 | 0.900 | - | - | Mlig455_021566 {REF} {Length: 3532} {Pfam: G-protein alpha subunit [PF00503.22, score=404.9]; ADP-ribosylation factor family [PF00025.23, score=56.0]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=20.1]; Gtr1/RagA G protein conserved region [PF04670.14, score=19.4]} {Human: ENSG00000127955, GNAI1, G protein subunit alpha i1, [Score=486, Expect=2e-171]; ENSG00000114353, GNAI2, G protein subunit alpha i2, [Score=481, Expect=3e-169]; ENSG00000065135, GNAI3, G protein subunit alpha i3, [Score=474, Expect=1e-166]} {Mouse: ENSMUSG00000057614, Gnai1, guanine nucleotide binding protein (G protein), alpha inhibiting 1, [Score=486, Expect=2e-171]; ENSMUSG00000032562, Gnai2, guanine nucleotide binding protein (G protein), alpha inhibiting 2, [Score=475, Expect=5e-167]; ENSMUSG00000000001, Gnai3, guanine nucleotide binding protein (G protein), alpha inhibiting 3, [Score=474, Expect=1e-166]} {Dmel: FBgn0001104, Galphai, G protein alpha i subunit, [Score=468, Expect=2e-164]} {Celegans: WBGene00001648, goa-1, Guanine nucleotide-binding protein G(o) subunit alpha, [Score=446, Expect=5e-156]} {Smed: dd_Smed_v6_12112_0_1, dd_Smed_v6_12112_0_1, [RH, Score=598, Expect=0.0]} {RNA1509_45426} {RNA1310_26920, RNA1509_45426} {RNA1509_45426, RNA815_11718} |
10. | MligTC455_22254 | 7695 | 160.31 | Mlig455_000728, Mlig455_000775 | Neo: - Age: - Region-specific R2: 6.574 Region-enriched R2: 5.474/0.00000 |
2.861 | 0.989 | - | 0.908 | 0.964 | - | - | Mlig455_000728 {REF} {Length: 129} {NoTransDecoderORF} {RNA1509_2230} {RNA1310_11420} {RNA815_16323} Mlig455_000775 {REF} {Length: 126} {NoTransDecoderORF} {RNA1509_2230} {RNA1310_11420} {RNA815_16323} |
|
11. | MligTC455_34524 | 155 | 3.22 | Mlig455_021291 | Neo: - Age: Down-Up-Down Region-specific R2: 4.905 Region-enriched R2: 4.200/0.01842 |
2.861 | 0.981 | - | 0.972 | 0.908 | - | - | Mlig455_021291 {REF} {Length: 1478} {NoTransDecoderORF} {RNA1509_56543} {RNA1310_26920, RNA1509_56543} {RNA1509_56543, RNA815_11718} | |
12. | MligTC455_09510 | 314 | 6.55 | Mlig455_001134, Mlig455_042048 | Neo: - Age: - Region-specific R2: 5.291 Region-enriched R2: 5.151/0.00029 |
2.835 | 0.950 | - | 0.957 | 0.928 | - | - | Mlig455_001134 {REF} {Length: 485} {Pfam: Fingers domain of DNA polymerase lambda [PF10391.11, score=26.9]} {RNA1310_8738.1} {RNA815_21682.1} Mlig455_042048 {REF} {Length: 1550} {Pfam: Fingers domain of DNA polymerase lambda [PF10391.11, score=32.1]} {Dmel: FBgn0036416, CG7924, [RH, Score=61.2, Expect=1e-10]} {RNA1509_51261} {RNA1310_8738.1} {RNA815_21682.1} |
|
13. | MligTC455_19616 | 70 | 1.46 | Mlig455_045100 | Neo: - Age: - |
RPH3A | 2.833 | 0.930 | - | 0.945 | 0.958 | - | - | Mlig455_045100 {REF} {Length: 2276} {Pfam: C2 domain [PF00168.32, score=141.3]} {Human: ENSG00000089169, RPH3A, rabphilin 3A, [RH, Score=247, Expect=9e-73]} {Mouse: ENSMUSG00000029608, Rph3a, rabphilin 3A, [RH, Score=244, Expect=9e-72]} {Dmel: FBgn0030230, Rph, Rabphilin, [Score=179, Expect=2e-50]} {Celegans: WBGene00004316, rbf-1, Rabphilin-1, [Score=209, Expect=6e-58]} {Smed: dd_Smed_v6_12977_0_1, dd_Smed_v6_12977_0_1, [Score=216, Expect=3e-62]} {RNA1310_30378} {RNA815_36857} |
14. | MligTC455_39544 | 611 | 12.73 | Mlig455_001809, Mlig455_001836, Mlig455_062227, Mlig455_062236 | Neo: - Age: - Region-specific R2: 8.576 Region-enriched R2: 8.112/0.00016 |
2.833 | 0.954 | - | 0.983 | 0.896 | - | - | Mlig455_001809 {REF} {Length: 1067} {RNA1509_52939} {RNA1310_72581} {RNA815_24546} Mlig455_001836 {REF} {Length: 1065} {RNA1509_52939} {RNA1310_72581, RNA1509_52939} {RNA1509_52939, RNA815_24546} Mlig455_062227 {REF} {Length: 3520} {RNA1509_52939} {RNA1310_72581} {RNA815_24546} Mlig455_062236 {REF} {Length: 620} {RNA1509_52939} {RNA1310_72581} {RNA815_24546} |
|
15. | MligTC455_21033 | 1129 | 23.52 | Mlig455_010672 | Neo: - Age: logFC(26M/2M)=0.356 Region-specific R2: 3.326 Region-enriched R2: 2.739/0.00000 Regeneration-downregulated R2: -1.967 Regeneration-depleted R2: -1.967 |
2.818 | 0.944 | - | 0.956 | 0.918 | - | - | Mlig455_010672 {REF} {Length: 829} {RNA1509_30331, RNA1509_45731} {RNA1310_60944, RNA1509_30331, RNA1509_45731} {RNA1509_30331, RNA1509_45731, RNA815_27381.1} | |
16. | MligTC455_17363 | 62 | 1.28 | Mlig455_003936 | Neo: - Age: - |
2.81 | 0.989 | - | 0.938 | 0.883 | - | - | Mlig455_003936 {REF} {Length: 1252} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=45.9]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=26.4]} {RNA1310_47889} {RNA815_24646} | |
17. | MligTC455_44713 | 661 | 13.77 | Mlig455_048154 | Neo: - Age: logFC(26M/2M)=0.569 Region-specific R2: 3.883 Region-enriched R2: 3.422/0.00000 |
2.81 | 0.933 | - | 0.902 | 0.975 | - | - | Mlig455_048154 {REF} {Length: 1173} {RNA1509_34252} {RNA1310_54269.1} {RNA815_55074} | |
18. | MligTC455_39838 | 117 | 2.44 | Mlig455_061337, Mlig455_062688 | Neo: - Age: Up-Down-Down Region-enriched R2: 5.720/0.01251 |
PROP1 | 2.809 | 0.965 | - | 0.916 | 0.928 | - | - | Mlig455_061337 {REF} {Length: 2182} {Pfam: Homeodomain [PF00046.31, score=77.0]} {Human: ENSG00000175325, PROP1, PROP paired-like homeobox 1, [RH, Score=97.8, Expect=9e-23]; ENSG00000274382, PROP1, PROP paired-like homeobox 1, [RH, Score=97.8, Expect=9e-23]} {Mouse: ENSMUSG00000028736, Pax7, paired box 7, [Score=103, Expect=4e-23]; ENSMUSG00000036602, Alx1, ALX homeobox 1, [Score=102, Expect=4e-24]; ENSMUSG00000024518, Rax, retina and anterior neural fold homeobox, [Score=101, Expect=3e-23]; ENSMUSG00000035277, Arx, aristaless related homeobox, [Score=100, Expect=4e-22]; ENSMUSG00000040310, Alx4, aristaless-like homeobox 4, [Score=100, Expect=9e-23]; ENSMUSG00000014603, Alx3, aristaless-like homeobox 3, [Score=99.0, Expect=2e-22]} {Dmel: FBgn0052532, CG32532, [RH, Score=188, Expect=3e-55]} {Celegans: WBGene00006778, unc-42, [RH, Score=152, Expect=1e-42]} {Smed: dd_Smed_v6_21801_0_1, dd_Smed_v6_21801_0_1, [RH, Score=211, Expect=9e-63]} {RNA1310_35015.1} {RNA815_23154} Mlig455_062688 {REF} {Length: 2531} {Pfam: Homeodomain [PF00046.31, score=77.5]} {Human: ENSG00000274382, PROP1, PROP paired-like homeobox 1, [RH, Score=99.0, Expect=1e-23]; ENSG00000175325, PROP1, PROP paired-like homeobox 1, [RH, Score=99.0, Expect=1e-23]} {Mouse: ENSMUSG00000036602, Alx1, ALX homeobox 1, [Score=103, Expect=5e-25]; ENSMUSG00000028736, Pax7, paired box 7, [Score=103, Expect=5e-24]; ENSMUSG00000024518, Rax, retina and anterior neural fold homeobox, [Score=102, Expect=4e-24]; ENSMUSG00000040310, Alx4, aristaless-like homeobox 4, [Score=102, Expect=8e-24]; ENSMUSG00000035277, Arx, aristaless related homeobox, [Score=101, Expect=4e-23]; ENSMUSG00000014603, Alx3, aristaless-like homeobox 3, [Score=100, Expect=2e-23]; ENSMUSG00000004872, Pax3, paired box 3, [Score=99.4, Expect=2e-22]; ENSMUSG00000012520, Phox2b, paired-like homeobox 2b, [Score=98.2, Expect=7e-23]} {Dmel: FBgn0052532, CG32532, [RH, Score=189, Expect=2e-56]} {Celegans: WBGene00006778, unc-42, [RH, Score=155, Expect=1e-44]} {Smed: dd_Smed_v6_21801_0_1, dd_Smed_v6_21801_0_1, [RH, Score=212, Expect=2e-64]} {RNA1310_35015.1} {RNA815_23154} |
19. | MligTC455_12183 | 53 | 1.11 | Mlig455_004166, Mlig455_004190 | Neo: - Age: - Region-enriched R2: 4.930/0.01881 |
2.807 | 0.980 | - | 0.906 | 0.921 | - | - | Mlig455_004166 {REF} {Length: 2818} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=57.4]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=29.1]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=55.5, Expect=1e-08]} {Smed: dd_Smed_v6_70862_0_1, dd_Smed_v6_70862_0_1, [Score=60.8, Expect=8e-12]} {RNA1310_64973} {RNA815_58453} Mlig455_004190 {REF} {Length: 2742} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=56.7]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=28.6]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=56.2, Expect=1e-08]} {Smed: dd_Smed_v6_70862_0_1, dd_Smed_v6_70862_0_1, [Score=60.8, Expect=1e-11]} {RNA1310_62602} {RNA815_58453} |
|
20. | MligTC455_51334 | 326 | 6.78 | Mlig455_011442, Mlig455_061180 | Neo: - |
2.806 | 0.932 | - | 0.985 | 0.889 | - | - | Mlig455_011442 {REF} {Length: 742} {RNA1310_57576.1} {RNA815_29867} Mlig455_061180 {REF} {Length: 769} {RNA1310_57576.1} {RNA815_29867} |
|
21. | MligTC455_33280 | 127 | 2.64 | Mlig455_010523 | Neo: - Age: Down-Up-Up |
2.804 | 0.972 | - | 0.886 | 0.946 | - | - | Mlig455_010523 {REF} {Length: 587} {RNA1509_48963} {RNA1310_65789} {RNA815_23468} | |
22. | MligTC455_47780 | 214 | 4.46 | Mlig455_018842, Mlig455_018853 | Neo: - Age: - |
2.802 | 0.911 | - | 0.974 | 0.917 | - | - | Mlig455_018842 {REF} {Length: 500} {RNA1509_48336} {RNA1310_73351} {RNA815_41082} Mlig455_018853 {REF} {Length: 593} {RNA1509_48336} {RNA1310_73351, RNA1509_48336} {RNA1509_48336, RNA815_41082} |
|
23. | MligTC455_45350 | 92 | 1.93 | Mlig455_024760, Mlig455_058317, Mlig455_068656 | Neo: - Age: Up-Down-Down |
SLC17A6, SLC17A8 | 2.801 | 0.928 | - | 0.979 | 0.894 | - | - | Mlig455_024760 {REF} {Length: 2935} {Pfam: Major Facilitator Superfamily [PF07690.18, score=158.2]} {Human: ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [RH, Score=531, Expect=0.0]; ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [RH, Score=531, Expect=0.0]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [RH, Score=522, Expect=5e-180]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [RH, Score=536, Expect=0.0]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [RH, Score=530, Expect=0.0]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [RH, Score=527, Expect=0.0]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=487, Expect=1e-165]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [RH, Score=474, Expect=3e-161]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [RH, Score=583, Expect=0.0]} {RNA1310_14405.1} {RNA815_24257} Mlig455_058317 {REF} {Length: 2971} {Pfam: Major Facilitator Superfamily [PF07690.18, score=157.7]} {Human: ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [RH, Score=534, Expect=0.0]; ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [RH, Score=531, Expect=0.0]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [RH, Score=521, Expect=8e-180]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [RH, Score=536, Expect=0.0]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [RH, Score=531, Expect=0.0]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [RH, Score=526, Expect=0.0]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=485, Expect=1e-164]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [Score=474, Expect=7e-162]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [Score=585, Expect=0.0]} {RNA1310_14405.1} {RNA815_24257} Mlig455_068656 {REF} {Length: 3034} {Pfam: Major Facilitator Superfamily [PF07690.18, score=158.2]} {Human: ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [RH, Score=531, Expect=0.0]; ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [RH, Score=531, Expect=0.0]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [RH, Score=522, Expect=5e-180]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [RH, Score=536, Expect=0.0]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [RH, Score=530, Expect=0.0]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [RH, Score=527, Expect=0.0]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=487, Expect=1e-165]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [RH, Score=474, Expect=3e-161]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [RH, Score=583, Expect=0.0]} {RNA1310_14405.1} {RNA815_24257} |
24. | MligTC455_15184 | 33 | 0.69 | Mlig455_065087 | Neo: - Age: - |
2.801 | 0.885 | - | 0.951 | 0.965 | - | - | Mlig455_065087 {REF} {Length: 2555} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.3]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=48.5, Expect=1e-05]} {Celegans: WBGene00009073, delm-1, DEgenerin Linked to Mechanosensation, [Score=68.2, Expect=1e-11]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [RH, Score=125, Expect=3e-30]} {RNA1310_11413} {RNA815_11497} | |
25. | MligTC455_10299 | 72 | 1.51 | Mlig455_023028, Mlig455_023125, Mlig455_023183 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.617 Region-enriched R2: 4.572/0.04281 |
ANGPTL1 | 2.8 | 0.957 | - | 0.920 | 0.923 | - | - | Mlig455_023028 {REF} {Length: 2538} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=130.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=115, Expect=8e-29]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=112, Expect=1e-27]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=114, Expect=2e-28]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=112, Expect=9e-28]} {Dmel: FBgn0050280, CG30280, [Score=103, Expect=9e-26]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=50.8, Expect=4e-08]} {RNA1509_41017} {RNA1310_41391} {RNA815_23568} Mlig455_023125 {REF} {Length: 2398} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=127.5]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=112, Expect=2e-27]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=107, Expect=1e-25]} {Mouse: ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=107, Expect=7e-26]} {Dmel: FBgn0050280, CG30280, [Score=92.8, Expect=6e-22]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=51.2, Expect=3e-08]} {RNA1509_41017} {RNA1310_41391} {RNA815_23568} Mlig455_023183 {REF} {Length: 2190} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=129.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=115, Expect=2e-28]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=110, Expect=9e-27]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=113, Expect=4e-28]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=110, Expect=6e-27]} {Dmel: FBgn0003326, sca, scabrous, [Score=104, Expect=8e-25]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=50.4, Expect=4e-08]} {RNA1509_41017} {RNA1310_41391} {RNA815_23568} |
26. | MligTC455_49919 | 745 | 15.52 | Mlig455_017182, Mlig455_048150 | Neo: - Age: - Region-specific R2: 7.180 Region-enriched R2: 7.978/0.00000 Regeneration-downregulated R2: -4.649 Regeneration-depleted R2: -4.649 |
2.798 | 0.906 | - | 0.977 | 0.915 | - | - | Mlig455_017182 {REF} {Length: 576} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1310_60849, RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1509_35830, RNA1509_49816, RNA1509_53987, RNA815_31347} Mlig455_048150 {REF} {Length: 574} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830} {RNA1310_60849} {RNA815_31347} |
|
27. | MligTC455_45943 | 66 | 1.38 | Mlig455_012164 | Neo: - Age: Up-Up-Down |
NPR2 | 2.787 | 0.932 | - | - | 0.954 | 0.901 | - | Mlig455_012164 {REF} {Length: 4580} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=225.3]; Receptor family ligand binding region [PF01094.30, score=169.5]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=126.7]; Protein kinase domain [PF00069.27, score=114.0]; Heme NO binding associated [PF07701.16, score=19.2]} {Human: ENSG00000159899, NPR2, natriuretic peptide receptor 2, [RH, Score=791, Expect=0.0]} {Mouse: ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [RH, Score=629, Expect=0.0]} {Dmel: FBgn0051183, CG31183, [RH, Score=826, Expect=0.0]} {Celegans: WBGene00020131, gcy-28, Receptor-type guanylate cyclase gcy-28, [RH, Score=600, Expect=0.0]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [RH, Score=955, Expect=0.0]} {RNA1509_42903} {RNA1310_5627} {RNA815_1811} |
28. | MligTC455_27799 | 414 | 8.62 | Mlig455_004285, Mlig455_004370 | Neo: - Age: Down-Up-Down Region-specific R2: 3.850 Region-enriched R2: 5.047/0.00000 |
2.786 | 0.968 | - | 0.924 | 0.894 | - | - | Mlig455_004285 {REF} {Length: 650} {RNA1509_56105} {RNA1310_32410} {RNA815_17871.1} Mlig455_004370 {REF} {Length: 1653} {RNA1509_56105} {RNA1310_32410} {RNA815_17871.1} |
|
29. | MligTC455_34369 | 112 | 2.34 | Mlig455_015308, Mlig455_015354, Mlig455_036248, Mlig455_068737, Mlig455_070110 | Neo: - Age: Up-Down-Up Region-enriched R2: 5.462/0.00546 |
2.78 | 0.963 | - | 0.998 | 0.819 | - | - | Mlig455_015308 {REF} {Length: 1459} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=63.9]} {RNA1310_34740} {RNA815_15663} Mlig455_015354 {REF} {Length: 1446} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=66.3]; Sialidase, N-terminal domain [PF02973.18, score=18.5]} {RNA1310_34740} {RNA815_15663} Mlig455_036248 {REF} {Length: 2111} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=120.9]; Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=28.5]; PAN domain [PF00024.28, score=19.9]} {RNA1509_45496} {RNA1310_2539.1} {RNA815_252.1} Mlig455_068737 {REF} {Length: 1096} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=68.3]; Sialidase, N-terminal domain [PF02973.18, score=19.9]} {RNA1310_34740} {RNA815_37905} Mlig455_070110 {REF} {Length: 1340} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=109.6]} {RNA1509_32599} {RNA1310_1659} {RNA815_252.1} |
|
30. | MligTC455_50253 | 44 | 0.92 | Mlig455_031495 | Neo: - Age: - |
GABRB2 | 2.772 | 0.984 | - | 0.928 | 0.860 | - | - | Mlig455_031495 {REF} {Length: 2129} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=58.3]} {Human: ENSG00000145864, GABRB2, gamma-aminobutyric acid type A receptor beta2 subunit, [Score=71.2, Expect=6e-14]} {Mouse: ENSMUSG00000007653, Gabrb2, gamma-aminobutyric acid (GABA) A receptor, subunit beta 2, [Score=67.8, Expect=1e-12]; ENSMUSG00000029212, Gabrb1, gamma-aminobutyric acid (GABA) A receptor, subunit beta 1, [Score=67.4, Expect=1e-12]} {Dmel: FBgn0024963, GluClalpha, [Score=54.3, Expect=3e-08]} {Celegans: WBGene00001594, glc-4, Glutamate-gated ChLoride channel, [Score=66.6, Expect=2e-12]} {Smed: dd_Smed_v6_15331_0_1, dd_Smed_v6_15331_0_1, [Score=70.1, Expect=9e-14]} {RNA1310_46931} {RNA815_25428} |
31. | MligTC455_09874 | 31 | 0.65 | Mlig455_045071 | Neo: - Age: - |
DOC2A | 2.769 | 0.956 | - | 0.883 | 0.930 | - | - | Mlig455_045071 {REF} {Length: 1760} {Pfam: C2 domain [PF00168.32, score=55.9]} {Human: ENSG00000149927, DOC2A, double C2 domain alpha, [Score=55.8, Expect=7e-08]} {Mouse: ENSMUSG00000052301, Doc2a, double C2, alpha, [Score=55.5, Expect=7e-08]} {Celegans: WBGene00004923, snt-3, SyNapTotagmin, [Score=70.5, Expect=2e-13]} {Smed: dd_Smed_v6_16731_0_1, dd_Smed_v6_16731_0_1, [Score=112, Expect=7e-27]} {RNA1310_36283} {RNA815_40844} |
32. | MligTC455_38162 | 710 | 14.8 | Mlig455_045004 | Neo: - Age: Down-Up-Up Region-specific R2: 5.269 Region-enriched R2: 5.838/0.00000 Regeneration-downregulated R2: -4.412 Regeneration-depleted R2: -4.412 |
2.765 | 0.946 | - | 0.966 | 0.853 | - | - | Mlig455_045004 {REF} {Length: 659} {Smed: dd_Smed_v6_4046_0_1, dd_Smed_v6_4046_0_1, [Score=57.8, Expect=2e-12]} {RNA1509_50998, RNA1509_57106} {RNA1310_56015, RNA1509_50998, RNA1509_57106} {RNA1509_50998, RNA1509_57106, RNA815_29915} | |
33. | MligTC455_29119 | 68 | 1.42 | Mlig455_050458 | Neo: - Age: - Region-enriched R2: 5.525/0.01281 |
2.76 | 0.991 | - | 0.909 | 0.860 | - | - | Mlig455_050458 {REF} {Length: 624} {RNA1509_53840} {RNA1310_67192} {RNA815_27042} | |
34. | MligTC455_19249 | 90 | 1.86 | Mlig455_054092 | Neo: - Age: Down-Up-Up Region-enriched R2: 7.298/0.00139 |
2.759 | 0.953 | - | 0.887 | 0.919 | - | - | Mlig455_054092 {REF} {Length: 667} {TRANSSPLICED} {RNA1509_57448} {RNA1310_51394, RNA1509_57448} {RNA1509_57448, RNA815_26076} | |
35. | MligTC455_29914 | 44 | 0.91 | Mlig455_027923 | Neo: - Age: Down-Up-Down Region-enriched R2: 8.096/0.00455 |
ANGPTL3 | 2.758 | 0.934 | - | 0.982 | 0.842 | - | - | Mlig455_027923 {REF} {Length: 1663} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=70.5]} {Human: ENSG00000132855, ANGPTL3, angiopoietin like 3, [Score=60.5, Expect=9e-10]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=59.3, Expect=2e-09]; ENSG00000120332, TNN, tenascin N, [Score=58.9, Expect=3e-09]} {Mouse: ENSMUSG00000015829, Tnr, tenascin R, [Score=62.4, Expect=2e-10]} {Dmel: FBgn0031804, CG9500, [Score=76.3, Expect=6e-16]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=51.2, Expect=3e-07]} {RNA1509_53291} {RNA1310_58974} {RNA815_43288.3} |
36. | MligTC455_39988 | 83 | 1.73 | Mlig455_062081 | Neo: - Age: - |
2.758 | 0.965 | - | 0.990 | 0.803 | - | - | Mlig455_062081 {REF} {Length: 447} {NoTransDecoderORF} {RNA1509_50426} {RNA1310_88257} {RNA815_17173.4} | |
37. | MligTC455_16358 | 1175 | 24.47 | Mlig455_039878 | Neo: - Age: - Region-specific R2: 4.659 Region-enriched R2: 4.310/0.00000 |
2.748 | 0.905 | - | 0.950 | 0.893 | - | - | Mlig455_039878 {REF} {Length: 1188} {RNA1509_60020} {RNA1310_35099.1, RNA1509_60020} {RNA1509_60020, RNA815_1356.1} | |
38. | MligTC455_17579 | 76 | 1.58 | Mlig455_042836, Mlig455_045854, Mlig455_045870 | Neo: - Age: - |
RNF217 | 2.746 | 0.852 | - | 0.987 | 0.907 | - | - | Mlig455_042836 {REF} {Length: 3004} {Pfam: IBR domain, a half RING-finger domain [PF01485.23, score=75.3]} {Human: ENSG00000146373, RNF217, ring finger protein 217, [Score=83.6, Expect=5e-16]} {Mouse: ENSMUSG00000063760, Rnf217, ring finger protein 217, [Score=83.2, Expect=4e-16]} {Dmel: FBgn0036082, CG12362, [Score=57.0, Expect=4e-08]} {Celegans: WBGene00020462, T12E12.1, Potential E3 ubiquitin-protein ligase ariadne-2, [Score=57.0, Expect=4e-08]} {Smed: dd_Smed_v6_7986_0_1, dd_Smed_v6_7986_0_1, [Score=61.2, Expect=1e-09]} {RNA1310_42946} {RNA815_24345} Mlig455_045854 {REF} {Length: 3004} {Pfam: IBR domain, a half RING-finger domain [PF01485.23, score=74.7]} {Human: ENSG00000146373, RNF217, ring finger protein 217, [Score=83.2, Expect=5e-16]} {Mouse: ENSMUSG00000063760, Rnf217, ring finger protein 217, [Score=83.2, Expect=4e-16]} {Dmel: FBgn0036082, CG12362, [Score=57.4, Expect=3e-08]} {Celegans: WBGene00020462, T12E12.1, Potential E3 ubiquitin-protein ligase ariadne-2, [Score=57.8, Expect=2e-08]} {Smed: dd_Smed_v6_7986_0_1, dd_Smed_v6_7986_0_1, [Score=61.2, Expect=1e-09]} {RNA1310_42946} {RNA815_24345} Mlig455_045870 {REF} {Length: 3004} {Pfam: IBR domain, a half RING-finger domain [PF01485.23, score=74.9]} {Human: ENSG00000146373, RNF217, ring finger protein 217, [Score=83.2, Expect=5e-16]} {Mouse: ENSMUSG00000063760, Rnf217, ring finger protein 217, [Score=83.2, Expect=4e-16]} {Dmel: FBgn0036082, CG12362, [Score=57.4, Expect=3e-08]} {Celegans: WBGene00020462, T12E12.1, Potential E3 ubiquitin-protein ligase ariadne-2, [Score=57.0, Expect=4e-08]} {Smed: dd_Smed_v6_7986_0_1, dd_Smed_v6_7986_0_1, [Score=61.2, Expect=1e-09]} {RNA1310_42946} {RNA815_24345} |
39. | MligTC455_24470 | 37 | 0.76 | Mlig455_020119 | Neo: - Age: - |
2.74 | 0.989 | - | 0.853 | 0.898 | - | - | Mlig455_020119 {REF} {Length: 1150} {Pfam: Pancreatic hormone peptide [PF00159.20, score=22.9]} {RNA1310_54016} {RNA815_51613} | |
40. | MligTC455_28695 | 95 | 1.98 | Mlig455_033490 | Neo: - Age: Up-Down-Down Region-enriched R2: 3.072/0.04773 |
PLCH2 | 2.74 | 0.901 | - | 0.976 | 0.863 | - | - | Mlig455_033490 {REF} {Length: 13918} {tRNA: Undet(NNN),pseudo, score=20.5} {Pfam: Phosphatidylinositol-specific phospholipase C, X domain [PF00388.21, score=199.7]; Phosphatidylinositol-specific phospholipase C, Y domain [PF00387.21, score=104.2]; RasGEF domain [PF00617.21, score=53.7]; Ras association (RalGDS/AF-6) domain [PF00788.25, score=44.8]; FERM central domain [PF00373.20, score=29.5]; C2 domain [PF00168.32, score=27.4]; Ankyrin repeat [PF00023.32, score=22.4]; Ankyrin repeats (3 copies) [PF12796.9, score=21.4]} {Human: ENSG00000276429, PLCH2, phospholipase C eta 2, [Score=325, Expect=2e-89]; ENSG00000149527, PLCH2, phospholipase C eta 2, [Score=325, Expect=2e-89]} {Mouse: ENSMUSG00000024998, Plce1, phospholipase C, epsilon 1, [RH, Score=281, Expect=4e-75]} {Dmel: FBgn0003416, sl, small wing, [Score=167, Expect=1e-40]} {Celegans: WBGene00004036, plc-1, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1, [Score=248, Expect=3e-65]} {Smed: dd_Smed_v6_9716_1_1, dd_Smed_v6_9716_1_1, [RH, Score=739, Expect=0.0]} {RNA1509_26054} {RNA1310_1143.2, RNA1509_26054} {RNA1509_26054, RNA815_10233} |
41. | MligTC455_54305 | 43 | 0.89 | Mlig455_035878, Mlig455_035917 | Neo: - Age: - |
ZC3H10 | 2.737 | 0.918 | - | 0.856 | 0.963 | - | - | Mlig455_035878 {REF} {Length: 2474} {tRNA: Val(CAC),pseudo, score=28.9} {Pfam: Zinc finger C-x8-C-x5-C-x3-H type (and similar) [PF00642.26, score=25.6]; CCCH-type zinc finger [PF18044.3, score=20.1]; Zinc-finger containing family [PF15663.7, score=19.3]; Mediator complex subunit 3 fungal [PF11593.10, score=18.0]} {Human: ENSG00000135482, ZC3H10, zinc finger CCCH-type containing 10, [Score=149, Expect=2e-40]} {Mouse: ENSMUSG00000039810, Zc3h10, zinc finger CCCH type containing 10, [Score=149, Expect=2e-40]} {Smed: dd_Smed_v6_7175_0_2, dd_Smed_v6_7175_0_2, [Score=119, Expect=4e-29]} {RNA1509_47157} {RNA1310_87786} {RNA815_46414} Mlig455_035917 {REF} {Length: 2428} {tRNA: Val(CAC),pseudo, score=30.2} {Pfam: Zinc finger C-x8-C-x5-C-x3-H type (and similar) [PF00642.26, score=25.6]; CCCH-type zinc finger [PF18044.3, score=20.1]; Zinc-finger containing family [PF15663.7, score=19.3]; Mediator complex subunit 3 fungal [PF11593.10, score=18.0]} {Human: ENSG00000135482, ZC3H10, zinc finger CCCH-type containing 10, [Score=149, Expect=2e-40]} {Mouse: ENSMUSG00000039810, Zc3h10, zinc finger CCCH type containing 10, [Score=149, Expect=2e-40]} {Smed: dd_Smed_v6_7175_0_2, dd_Smed_v6_7175_0_2, [Score=119, Expect=4e-29]} {RNA1509_47157} {RNA1310_87786} {RNA815_46414} |
42. | MligTC455_37200 | 32 | 0.67 | Mlig455_030215, Mlig455_030221, Mlig455_067995, Mlig455_067998 | Neo: - Age: - |
2.735 | 0.989 | - | 0.879 | 0.867 | - | - | Mlig455_030215 {REF} {Length: 1088} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=23.5]} {Smed: dd_Smed_v6_26560_0_2, dd_Smed_v6_26560_0_2, [Score=106, Expect=1e-25]} {RNA1310_102374} Mlig455_030221 {REF} {Length: 1980} {RNA1310_56149} {RNA815_31265} Mlig455_067995 {REF} {Length: 792} {Pfam: SAP domain [PF02037.29, score=35.7]} {RNA1509_8096} {RNA1310_1771} {RNA815_801} Mlig455_067998 {REF} {Length: 1295} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=24.0]} {Smed: dd_Smed_v6_26560_0_2, dd_Smed_v6_26560_0_2, [Score=105, Expect=2e-25]} {RNA1310_102374} |
|
43. | MligTC455_44525 | 3358 | 69.96 | Mlig455_004678, Mlig455_004741, Mlig455_004755, Mlig455_004840 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.742 Region-enriched R2: 10.296/0.00000 |
2.734 | 0.869 | - | 0.984 | 0.881 | - | - | Mlig455_004678 {REF} {Length: 845} {RNA1509_25712} {RNA1310_68954.2} {RNA815_35323} Mlig455_004741 {REF} {Length: 961} {RNA1509_25712} {RNA1310_68954.1} {RNA815_35323} Mlig455_004755 {REF} {Length: 1059} {RNA1509_25712} {RNA1310_68954.2} {RNA815_35323} Mlig455_004840 {REF} {Length: 918} {RNA1509_25712, RNA1509_29691} {RNA1310_68954.2, RNA1509_25712, RNA1509_29691} {RNA1509_25712, RNA1509_29691, RNA815_35323} |
|
44. | MligTC455_50844 | 224 | 4.67 | Mlig455_018511 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.591/0.00005 |
SSUH2 | 2.733 | 0.930 | - | 0.950 | 0.853 | - | - | Mlig455_018511 {REF} {Length: 1843} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=120, Expect=2e-29]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=95.5, Expect=3e-21]} {RNA1509_39980} {RNA1310_60742, RNA1509_39980} {RNA1509_39980, RNA815_28938} |
45. | MligTC455_34655 | 89 | 1.86 | Mlig455_058020, Mlig455_058176 | Neo: - Age: - Region-enriched R2: 5.798/0.00826 |
PPEF1 | 2.725 | 0.867 | - | 0.880 | 0.978 | - | - | Mlig455_058020 {REF} {Length: 3007} {Pfam: Calcineurin-like phosphoesterase [PF00149.30, score=84.9]; EF-hand domain pair [PF13499.8, score=77.8]; EF hand [PF00036.34, score=66.0]; EF-hand domain pair [PF13833.8, score=52.1]; EF-hand domain [PF13405.8, score=48.4]; EF hand [PF13202.8, score=38.2]; PPP5 TPR repeat region [PF08321.14, score=37.0]; EF-hand domain [PF14658.8, score=23.0]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=20.4]} {Human: ENSG00000086717, PPEF1, protein phosphatase with EF-hand domain 1, [Score=416, Expect=2e-138]} {Mouse: ENSMUSG00000062168, Ppef1, protein phosphatase with EF hand calcium-binding domain 1, [Score=413, Expect=9e-138]} {Dmel: FBgn0265959, rdgC, retinal degeneration C, [Score=404, Expect=3e-134]} {Celegans: WBGene00003969, pef-1, Serine/threonine-protein phosphatase with EF-hands pef-1, [Score=455, Expect=2e-155]} {Smed: dd_Smed_v6_11874_0_2, dd_Smed_v6_11874_0_2, [Score=516, Expect=2e-178]} {RNA1509_3508} {RNA1310_10928.2} {RNA815_11707} Mlig455_058176 {REF} {Length: 3371} {Pfam: Calcineurin-like phosphoesterase [PF00149.30, score=102.6]; EF-hand domain pair [PF13499.8, score=72.6]; EF hand [PF00036.34, score=64.2]; EF-hand domain pair [PF13833.8, score=51.3]; EF-hand domain [PF13405.8, score=46.1]; EF hand [PF13202.8, score=36.7]; PPP5 TPR repeat region [PF08321.14, score=36.6]; EF-hand domain [PF14658.8, score=26.5]; IQ calmodulin-binding motif [PF00612.29, score=21.3]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=19.8]} {Human: ENSG00000086717, PPEF1, protein phosphatase with EF-hand domain 1, [RH, Score=546, Expect=0.0]} {Mouse: ENSMUSG00000062168, Ppef1, protein phosphatase with EF hand calcium-binding domain 1, [Score=520, Expect=3e-177]} {Dmel: FBgn0265959, rdgC, retinal degeneration C, [Score=529, Expect=2e-180]} {Celegans: WBGene00003969, pef-1, Serine/threonine-protein phosphatase with EF-hands pef-1, [Score=598, Expect=0.0]} {Smed: dd_Smed_v6_11874_0_1, dd_Smed_v6_11874_0_1, [Score=671, Expect=0.0]} {RNA1509_3508} {RNA1310_10928.2} {RNA815_11707} |
46. | MligTC455_26678 | 44 | 0.92 | Mlig455_004705 | Neo: - Age: - |
2.706 | 0.822 | - | 0.959 | 0.925 | - | - | Mlig455_004705 {REF} {Length: 311} {NoTransDecoderORF} {RNA1310_55436} {RNA815_42049.1} | |
47. | MligTC455_35813 | 35 | 0.73 | Mlig455_013562, Mlig455_013615 | Neo: - Age: - Region-enriched R2: 7.733/0.00085 |
NPR2 | 2.701 | 0.989 | - | 0.897 | 0.815 | - | - | Mlig455_013562 {REF} {Length: 3105} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=187.6]; Nitrate and nitrite sensing [PF08376.12, score=108.9]; Heme NO binding associated [PF07701.16, score=29.1]} {Human: ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=251, Expect=2e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=247, Expect=6e-69]; ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=241, Expect=1e-66]} {Mouse: ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=252, Expect=1e-73]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=248, Expect=2e-69]} {Dmel: FBgn0053958, CG33958, [Score=330, Expect=3e-102]} {Celegans: WBGene00001533, gcy-6, Receptor-type guanylate cyclase gcy-6, [Score=231, Expect=7e-64]} {Smed: dd_Smed_v6_11767_0_1, dd_Smed_v6_11767_0_1, [Score=244, Expect=3e-68]} {RNA1310_16282} {RNA815_27869} Mlig455_013615 {REF} {Length: 2993} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=187.7]; Nitrate and nitrite sensing [PF08376.12, score=109.5]; Heme NO binding associated [PF07701.16, score=29.1]} {Human: ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=251, Expect=2e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=246, Expect=8e-69]; ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=241, Expect=1e-66]} {Mouse: ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=252, Expect=9e-74]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=247, Expect=2e-69]} {Dmel: FBgn0053958, CG33958, [Score=331, Expect=1e-102]} {Celegans: WBGene00001533, gcy-6, Receptor-type guanylate cyclase gcy-6, [Score=231, Expect=8e-64]} {Smed: dd_Smed_v6_11767_0_1, dd_Smed_v6_11767_0_1, [Score=244, Expect=3e-68]} {RNA1310_16282} {RNA815_33407} |
48. | MligTC455_52656 | 121 | 2.51 | Mlig455_062381, Mlig455_062408 | Neo: - Age: Down-Up-Down |
2.701 | 0.981 | - | 0.756 | 0.964 | - | - | Mlig455_062381 {REF} {Length: 2245} {RNA1310_26272} {RNA815_22826} Mlig455_062408 {REF} {Length: 2277} {RNA1310_26272} {RNA815_37592} |
|
49. | MligTC455_47792 | 666 | 13.88 | Mlig455_041913 | Neo: - Age: - Region-specific R2: 4.721 Region-enriched R2: 5.442/0.00000 |
2.7 | 0.879 | - | 0.868 | 0.953 | - | - | Mlig455_041913 {REF} {Length: 603} {RNA1509_14790} {RNA1310_58119} {RNA815_32986} | |
50. | MligTC455_33287 | 444 | 9.24 | Mlig455_061811 | Neo: - Age: - Region-enriched R2: 4.031/0.00004 |
2.699 | 0.862 | - | 0.883 | 0.954 | - | - | Mlig455_061811 {REF} {Length: 782} {RNA1509_48963} {RNA1310_53012} {RNA815_23468} | |
51. | MligTC455_18099 | 24 | 0.51 | Mlig455_036525 | Neo: - Age: - |
PPA1 | 2.697 | 0.989 | - | 0.888 | 0.820 | - | - | Mlig455_036525 {REF} {Length: 1911} {Pfam: Inorganic pyrophosphatase [PF00719.21, score=181.8]} {Human: ENSG00000180817, PPA1, pyrophosphatase (inorganic) 1, [Score=304, Expect=2e-103]; ENSG00000138777, PPA2, pyrophosphatase (inorganic) 2, [Score=295, Expect=4e-99]} {Mouse: ENSMUSG00000020089, Ppa1, pyrophosphatase (inorganic) 1, [Score=307, Expect=9e-105]} {Dmel: FBgn0016687, Nurf-38, Nucleosome remodeling factor - 38kD, [Score=303, Expect=2e-103]} {Celegans: WBGene00008149, pyp-1, Probable inorganic pyrophosphatase 1, [Score=315, Expect=5e-108]} {Smed: dd_Smed_v6_625_0_1, dd_Smed_v6_625_0_1, [Score=290, Expect=2e-98]} {RNA1310_57333.1} {RNA815_22340} |
52. | MligTC455_24064 | 359 | 7.48 | Mlig455_048183 | Neo: - Age: - |
SNAP25 | 2.697 | 0.955 | - | 0.917 | 0.825 | - | - | Mlig455_048183 {REF} {Length: 1315} {Pfam: SNAP-25 family [PF00835.21, score=41.5]} {Human: ENSG00000132639, SNAP25, synaptosome associated protein 25, [Score=219, Expect=7e-72]} {Mouse: ENSMUSG00000027273, Snap25, synaptosomal-associated protein 25, [Score=219, Expect=5e-72]} {Dmel: FBgn0266720, Snap24, Synaptosomal-associated protein 24kDa, [RH, Score=228, Expect=1e-75]} {Celegans: WBGene00004364, ric-4, Synaptosomal-associated protein, [RH, Score=257, Expect=2e-87]} {Smed: dd_Smed_v6_3977_0_1, dd_Smed_v6_3977_0_1, [RH, Score=282, Expect=2e-97]} {RNA1509_8624} {RNA1310_24253} {RNA815_10439} |
53. | MligTC455_43390 | 28 | 0.59 | Mlig455_064273 | Neo: - Age: Down-Up-Down |
PRKAR2A | 2.696 | 0.989 | - | 0.945 | 0.762 | - | - | Mlig455_064273 {REF} {Length: 2394} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=122.5]; Regulatory subunit of type II PKA R-subunit [PF02197.19, score=40.5]} {Human: ENSG00000114302, PRKAR2A, protein kinase cAMP-dependent type II regulatory subunit alpha, [Score=305, Expect=2e-100]; ENSG00000005249, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=296, Expect=8e-97]; ENSG00000284096, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=296, Expect=8e-97]} {Mouse: ENSMUSG00000032601, Prkar2a, protein kinase, cAMP dependent regulatory, type II alpha, [Score=314, Expect=6e-104]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=335, Expect=1e-112]} {Celegans: WBGene00002190, kin-2, cAMP-dependent protein kinase regulatory subunit, [Score=219, Expect=2e-68]} {Smed: dd_Smed_v6_4188_0_1, dd_Smed_v6_4188_0_1, [Score=335, Expect=5e-113]} {RNA1509_34470} {RNA1310_27777} {RNA815_5628} |
54. | MligTC455_42314 | 406 | 8.46 | Mlig455_052727 | Neo: - Age: - Region-enriched R2: 4.230/0.00183 |
2.687 | 0.931 | - | 0.806 | 0.950 | - | - | Mlig455_052727 {REF} {Length: 1339} {Pfam: Hyaluronidase protein (HylP) [PF07212.13, score=19.1]} {RNA1509_51722} {RNA1310_50605} {RNA815_15783.1} | |
55. | MligTC455_44966 | 574 | 11.95 | Mlig455_036578, Mlig455_057773 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.756 Region-specific R2: 7.016 Region-enriched R2: 7.690/0.00000 |
2.677 | 0.989 | - | 0.793 | 0.895 | - | - | Mlig455_036578 {REF} {Length: 1101} {RNA1509_34765} {RNA1310_57079} {RNA815_29388} Mlig455_057773 {REF} {Length: 629} {RNA1509_34765} {RNA1310_57079, RNA1509_34765} {RNA1509_34765, RNA815_29388} |
|
56. | MligTC455_46155 | 116 | 2.42 | Mlig455_027239 | Neo: - Age: - Region-enriched R2: 4.163/0.03818 |
GRK3 | 2.675 | 0.927 | - | 0.773 | 0.975 | - | - | Mlig455_027239 {REF} {Length: 2919} {Pfam: Protein kinase domain [PF00069.27, score=226.6]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=100.5]; Regulator of G protein signaling domain [PF00615.21, score=48.3]} {Human: ENSG00000100077, GRK3, G protein-coupled receptor kinase 3, [Score=845, Expect=0.0]; ENSG00000173020, GRK2, G protein-coupled receptor kinase 2, [Score=838, Expect=0.0]} {Mouse: ENSMUSG00000042249, Grk3, G protein-coupled receptor kinase 3, [Score=838, Expect=0.0]; ENSMUSG00000024858, Grk2, G protein-coupled receptor kinase 2, [Score=838, Expect=0.0]} {Dmel: FBgn0260798, Gprk1, G protein-coupled receptor kinase 1, [Score=842, Expect=0.0]} {Celegans: WBGene00001709, grk-2, G protein-coupled receptor kinase 2, [Score=819, Expect=0.0]} {Smed: dd_Smed_v6_6480_0_1, dd_Smed_v6_6480_0_1, [Score=949, Expect=0.0]} {RNA1509_7002} {RNA1310_16658} {RNA815_28070} |
57. | MligTC455_11701 | 54 | 1.12 | Mlig455_042837, Mlig455_045855, Mlig455_045871 | Neo: - Age: - |
2.674 | 0.989 | - | - | 0.898 | 0.787 | - | Mlig455_042837 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} Mlig455_045855 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} Mlig455_045871 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} |
|
58. | MligTC455_19775 | 36 | 0.74 | Mlig455_060359 | Neo: - Age: - |
FCN1 | 2.668 | 0.989 | - | 0.874 | - | 0.805 | - | Mlig455_060359 {REF} {Length: 1109} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=120.9]} {Human: ENSG00000085265, FCN1, ficolin 1, [Score=99.0, Expect=2e-23]; ENSG00000142748, FCN3, ficolin 3, [Score=99.0, Expect=1e-23]; ENSG00000160339, FCN2, ficolin 2, [Score=98.2, Expect=2e-23]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=100, Expect=3e-24]} {Dmel: FBgn0034160, CG5550, [Score=97.8, Expect=7e-24]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=90.1, Expect=4e-20]} {RNA1310_67383} {RNA815_45536} |
59. | MligTC455_37838 | 40 | 0.83 | Mlig455_012885 | Neo: - Age: Up-Down-Down |
PKDREJ | 2.662 | 0.967 | - | - | 0.903 | 0.792 | - | Mlig455_012885 {REF} {Length: 13341} {Pfam: Polycystin cation channel [PF08016.14, score=221.2]; REJ domain [PF02010.17, score=52.8]; PLAT/LH2 domain [PF01477.25, score=27.5]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [Score=184, Expect=7e-46]} {Mouse: ENSMUSG00000052496, Pkdrej, polycystin (PKD) family receptor for egg jelly, [Score=186, Expect=7e-47]; ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=178, Expect=3e-44]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=110, Expect=6e-24]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=121, Expect=3e-27]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=260, Expect=1e-69]} {RNA1509_38015} {RNA1310_23208, RNA1509_38015} {RNA1509_38015, RNA815_31966} |
60. | MligTC455_13421 | 86 | 1.79 | Mlig455_036504, Mlig455_069144 | Neo: - Age: - |
SYT17 | 2.658 | 0.982 | - | 0.789 | 0.887 | - | - | Mlig455_036504 {REF} {Length: 2390} {Pfam: C2 domain [PF00168.32, score=84.3]} {Human: ENSG00000103528, SYT17, synaptotagmin 17, [Score=137, Expect=5e-35]} {Mouse: ENSMUSG00000058420, Syt17, synaptotagmin XVII, [Score=137, Expect=6e-35]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [Score=101, Expect=1e-22]} {Celegans: WBGene00004922, snt-2, Synaptotagmin 2, [Score=105, Expect=2e-24]} {Smed: dd_Smed_v6_19213_0_1, dd_Smed_v6_19213_0_1, [RH, Score=124, Expect=2e-30]} {RNA1310_17303} {RNA815_33031} Mlig455_069144 {REF} {Length: 1355} {Pfam: C2 domain [PF00168.32, score=84.3]} {Human: ENSG00000103528, SYT17, synaptotagmin 17, [Score=137, Expect=5e-35]} {Mouse: ENSMUSG00000058420, Syt17, synaptotagmin XVII, [Score=137, Expect=6e-35]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [Score=101, Expect=1e-22]} {Celegans: WBGene00004922, snt-2, Synaptotagmin 2, [Score=105, Expect=2e-24]} {Smed: dd_Smed_v6_19213_0_1, dd_Smed_v6_19213_0_1, [RH, Score=124, Expect=2e-30]} {RNA1310_17303} {RNA815_33031} |
61. | MligTC455_18270 | 68 | 1.42 | Mlig455_002895, Mlig455_002898 | Neo: - Age: - Region-enriched R2: 5.462/0.00338 |
CDK5R1, CDK5R2 | 2.657 | 0.811 | - | 0.895 | 0.951 | - | - | Mlig455_002895 {REF} {Length: 2279} {Pfam: Cyclin-dependent kinase 5 activator protein [PF03261.17, score=254.4]} {Human: ENSG00000171450, CDK5R2, cyclin dependent kinase 5 regulatory subunit 2, [RH, Score=173, Expect=8e-51]} {Mouse: ENSMUSG00000090071, Cdk5r2, cyclin-dependent kinase 5, regulatory subunit 2 (p39), [RH, Score=173, Expect=6e-51]} {Dmel: FBgn0027491, Cdk5alpha, Cdk5 activator-like protein, [RH, Score=193, Expect=2e-57]} {Celegans: WBGene00011955, cdka-1, Cyclin-dependent kinase 5 activator 1, [Score=170, Expect=7e-50]} {Smed: dd_Smed_v6_13788_0_1, dd_Smed_v6_13788_0_1, [Score=202, Expect=6e-63]} {RNA1310_36625} {RNA815_39057} Mlig455_002898 {REF} {Length: 2204} {Pfam: Cyclin-dependent kinase 5 activator protein [PF03261.17, score=252.9]} {Human: ENSG00000176749, CDK5R1, cyclin dependent kinase 5 regulatory subunit 1, [Score=176, Expect=2e-52]; ENSG00000171450, CDK5R2, cyclin dependent kinase 5 regulatory subunit 2, [Score=172, Expect=3e-50]} {Mouse: ENSMUSG00000090071, Cdk5r2, cyclin-dependent kinase 5, regulatory subunit 2 (p39), [RH, Score=172, Expect=2e-50]} {Dmel: FBgn0027491, Cdk5alpha, Cdk5 activator-like protein, [RH, Score=193, Expect=2e-57]} {Celegans: WBGene00011955, cdka-1, Cyclin-dependent kinase 5 activator 1, [Score=169, Expect=1e-49]} {Smed: dd_Smed_v6_13788_0_1, dd_Smed_v6_13788_0_1, [Score=196, Expect=1e-60]} {RNA1310_36625} {RNA815_39057} |
62. | MligTC455_40340 | 201 | 4.19 | Mlig455_021026, Mlig455_021062 | Neo: - Age: - |
2.657 | 0.767 | - | 0.969 | 0.921 | - | - | Mlig455_021026 {REF} {Length: 1609} {RNA1310_21018} {RNA815_22069} Mlig455_021062 {REF} {Length: 1582} {RNA1310_21018} {RNA815_22069} |
|
63. | MligTC455_39013 | 53 | 1.1 | Mlig455_030082 | Neo: - Age: Up-Down-Down |
PLCB1 | 2.656 | 0.919 | - | - | 0.768 | 0.969 | - | Mlig455_030082 {REF} {Length: 5740} {Pfam: Phosphatidylinositol-specific phospholipase C, X domain [PF00388.21, score=199.2]; Phosphatidylinositol-specific phospholipase C, Y domain [PF00387.21, score=124.4]; PH domain [PF17787.3, score=120.6]; Phosphoinositide-specific phospholipase C, efhand-like [PF09279.13, score=33.9]} {Human: ENSG00000182621, PLCB1, phospholipase C beta 1, [RH, Score=826, Expect=0.0]; ENSG00000149782, PLCB3, phospholipase C beta 3, [RH, Score=824, Expect=0.0]} {Mouse: ENSMUSG00000051177, Plcb1, phospholipase C, beta 1, [RH, Score=826, Expect=0.0]; ENSMUSG00000024960, Plcb3, phospholipase C, beta 3, [RH, Score=813, Expect=0.0]} {Dmel: FBgn0262738, norpA, no receptor potential A, [Score=670, Expect=0.0]} {Celegans: WBGene00001177, egl-8, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta egl-8, [Score=680, Expect=0.0]} {Smed: dd_Smed_v6_3221_0_1, dd_Smed_v6_3221_0_1, [Score=724, Expect=0.0]} {RNA1509_47106} {RNA1310_7555, RNA1509_47106} {RNA1509_47106, RNA815_2033} |
64. | MligTC455_18333 | 273 | 5.7 | Mlig455_010935 | Neo: - Age: Down-Up-Up Region-enriched R2: 5.059/0.00307 |
2.655 | 0.964 | - | 0.783 | 0.908 | - | - | Mlig455_010935 {REF} {Length: 510} {RNA1310_33328.2} {RNA815_15093.1} | |
65. | MligTC455_29118 | 467 | 9.72 | Mlig455_040411 | Neo: - Age: - Region-specific R2: 6.456 Region-enriched R2: 5.344/0.00023 |
2.653 | 0.776 | - | 0.965 | 0.912 | - | - | Mlig455_040411 {REF} {Length: 599} {TRANSSPLICED} {RNA1509_53840} {RNA1310_67192, RNA1509_53840} {RNA1509_53840, RNA815_27042} | |
66. | MligTC455_17947 | 64 | 1.34 | Mlig455_042563 | Neo: - Age: - Region-enriched R2: 7.054/0.00113 |
ASCL5 | 2.642 | 0.855 | - | 0.990 | 0.797 | - | - | Mlig455_042563 {REF} {Length: 1821} {Pfam: Helix-loop-helix DNA-binding domain [PF00010.28, score=52.5]} {Human: ENSG00000232237, ASCL5, achaete-scute family bHLH transcription factor 5, [Score=84.7, Expect=6e-20]} {Mouse: ENSMUSG00000097918, Ascl5, achaete-scute family bHLH transcription factor 5, [Score=84.0, Expect=5e-20]} {Dmel: FBgn0002922, nau, nautilus, [Score=49.3, Expect=6e-07]} {Celegans: WBGene00001952, hlh-6, Helix-loop-helix protein 6, [RH, Score=90.9, Expect=4e-22]} {Smed: dd_Smed_v6_14753_0_1, dd_Smed_v6_14753_0_1, [RH, Score=76.6, Expect=2e-17]} {RNA1310_71187} |
67. | MligTC455_33040 | 203 | 4.23 | Mlig455_032497 | Neo: - Age: logFC(26M/2M)=0.515 Region-enriched R2: 4.005/0.00408 |
PKD2L1 | 2.639 | 0.931 | - | 0.995 | 0.713 | - | - | Mlig455_032497 {REF} {Length: 3318} {Pfam: Polycystin cation channel [PF08016.14, score=293.1]; Ion transport protein [PF00520.33, score=39.7]} {Human: ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [Score=236, Expect=4e-66]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=261, Expect=3e-73]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=131, Expect=5e-31]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=180, Expect=1e-47]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=641, Expect=0.0]} {RNA1509_3444} {RNA1310_89} {RNA815_1814} |
68. | MligTC455_48756 | 622 | 12.96 | Mlig455_054772, Mlig455_054799, Mlig455_054893 | Neo: - Age: - Region-specific R2: 7.873 Region-enriched R2: 9.003/0.00000 |
2.634 | 0.776 | - | 0.990 | 0.868 | - | - | Mlig455_054772 {REF} {Length: 716} {RNA1509_41507} {RNA1310_49516} {RNA815_28703} Mlig455_054799 {REF} {Length: 625} {RNA1509_41507} {RNA1310_49516} {RNA815_28703} Mlig455_054893 {REF} {Length: 947} {RNA1509_41507} {RNA1310_49516, RNA1509_41507} {RNA1509_41507, RNA815_28703} |
|
69. | MligTC455_46691 | 41 | 0.85 | Mlig455_018781, Mlig455_018951 | Neo: - Age: Up-Down-Down |
2.619 | 0.899 | - | 0.972 | 0.748 | - | - | Mlig455_018781 {REF} {Length: 1694} {Celegans: WBGene00021142, clec-133, C-type LECtin, [RH, Score=52.0, Expect=6e-08]} {RNA1310_43489} {RNA815_41340} Mlig455_018951 {REF} {Length: 2466} {Celegans: WBGene00021142, clec-133, C-type LECtin, [RH, Score=52.0, Expect=6e-08]} {RNA1310_38733.1} {RNA815_41340} |
|
70. | MligTC455_49073 | 824 | 17.17 | Mlig455_063174 | Neo: - Age: Down-Down-Up Region-specific R2: 4.151 Region-enriched R2: 3.105/0.00023 |
2.619 | 0.861 | - | 0.806 | 0.952 | - | - | Mlig455_063174 {REF} {Length: 1083} {RNA1509_9056} {RNA1310_56777} {RNA815_24608} | |
71. | MligTC455_12512 | 80 | 1.68 | Mlig455_017689 | Neo: - Age: - |
2.603 | 0.989 | - | 0.858 | 0.756 | - | - | Mlig455_017689 {REF} {Length: 934} {RNA1310_37507} {RNA815_32171} | |
72. | MligTC455_15586 | 179 | 3.72 | Mlig455_061074 | Neo: - Age: - Region-enriched R2: 6.557/0.00000 |
2.594 | 0.714 | - | 0.961 | 0.919 | - | - | Mlig455_061074 {REF} {Length: 997} {Dmel: FBgn0013467, igl, igloo, [Score=43.5, Expect=3e-06]} {Smed: dd_Smed_v6_4783_0_82, dd_Smed_v6_4783_0_82, [Score=70.1, Expect=6e-16]} {RNA1509_36803} {RNA1310_35463} {RNA815_8499} | |
73. | MligTC455_33704 | 135 | 2.81 | Mlig455_002733 | Neo: - Age: Up-Down-Down |
COL5A2 | 2.593 | 0.845 | - | 0.974 | 0.774 | - | - | Mlig455_002733 {REF} {Length: 6615} {Pfam: Collagen triple helix repeat (20 copies) [PF01391.20, score=136.4]; Myotubularin protein [PF12335.10, score=23.9]} {Human: ENSG00000204262, COL5A2, collagen type V alpha 2 chain, [Score=113, Expect=6e-25]; ENSG00000049089, COL9A2, collagen type IX alpha 2 chain, [Score=111, Expect=1e-24]} {Mouse: ENSMUSG00000026147, Col9a1, collagen, type IX, alpha 1, [Score=124, Expect=2e-28]; ENSMUSG00000026042, Col5a2, collagen, type V, alpha 2, [Score=122, Expect=1e-27]; ENSMUSG00000041984, Rptn, repetin, [Score=121, Expect=1e-27]; ENSMUSG00000045672, Col27a1, collagen, type XXVII, alpha 1, [Score=120, Expect=3e-27]} {Dmel: FBgn0016075, vkg, viking, [Score=106, Expect=5e-23]} {Celegans: WBGene00000708, col-135, COLlagen, [Score=84.0, Expect=2e-16]} {Smed: dd_Smed_v6_8075_0_1, dd_Smed_v6_8075_0_1, [Score=140, Expect=9e-34]} {RNA1310_28728} {RNA815_22052} |
74. | MligTC455_46022 | 51 | 1.07 | Mlig455_009838 | Neo: - Age: - |
2.59 | 0.861 | - | - | 0.951 | - | 0.778 | Mlig455_009838 {REF} {Length: 1632} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=54.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=20.2]} {Dmel: FBgn0038874, ETHR, [Score=50.1, Expect=2e-06]} {Smed: dd_Smed_v6_17171_0_1, dd_Smed_v6_17171_0_1, [Score=175, Expect=2e-51]} {RNA1310_62858} {RNA815_33606} | |
75. | MligTC455_45731 | 76 | 1.59 | Mlig455_003947, Mlig455_003964, Mlig455_005981 | Neo: - Age: Up-Down-Down |
TTLL7 | 2.588 | 0.712 | - | 0.994 | 0.882 | - | - | Mlig455_003947 {REF} {Length: 4060} {Pfam: Tubulin-tyrosine ligase family [PF03133.17, score=212.9]; Sugar-transfer associated ATP-grasp [PF14397.8, score=23.9]; YheC/D like ATP-grasp [PF14398.8, score=21.3]} {Human: ENSG00000137941, TTLL7, tubulin tyrosine ligase like 7, [Score=351, Expect=4e-107]} {Mouse: ENSMUSG00000036745, Ttll7, tubulin tyrosine ligase-like family, member 7, [Score=347, Expect=1e-103]} {Dmel: FBgn0039501, CG5987, [Score=235, Expect=3e-65]} {Celegans: WBGene00019230, ttll-11, Tubulin Tyrosine Ligase Like, [Score=158, Expect=4e-40]} {Smed: dd_Smed_v6_13600_0_1, dd_Smed_v6_13600_0_1, [Score=313, Expect=3e-91]} {RNA1310_17573} {RNA815_57268} Mlig455_003964 {REF} {Length: 3783} {Pfam: Tubulin-tyrosine ligase family [PF03133.17, score=213.2]; Sugar-transfer associated ATP-grasp [PF14397.8, score=23.9]; YheC/D like ATP-grasp [PF14398.8, score=21.3]} {Human: ENSG00000137941, TTLL7, tubulin tyrosine ligase like 7, [Score=353, Expect=2e-109]} {Mouse: ENSMUSG00000036745, Ttll7, tubulin tyrosine ligase-like family, member 7, [Score=349, Expect=2e-104]} {Dmel: FBgn0039501, CG5987, [Score=234, Expect=4e-65]} {Celegans: WBGene00019230, ttll-11, Tubulin Tyrosine Ligase Like, [Score=157, Expect=7e-40]} {Smed: dd_Smed_v6_13600_0_1, dd_Smed_v6_13600_0_1, [Score=312, Expect=4e-91]} {RNA1310_17573} {RNA815_57268} Mlig455_005981 {REF} {Length: 4222} {Pfam: Tubulin-tyrosine ligase family [PF03133.17, score=213.3]; Sugar-transfer associated ATP-grasp [PF14397.8, score=23.7]; YheC/D like ATP-grasp [PF14398.8, score=21.1]} {Human: ENSG00000137941, TTLL7, tubulin tyrosine ligase like 7, [Score=353, Expect=2e-107]} {Mouse: ENSMUSG00000036745, Ttll7, tubulin tyrosine ligase-like family, member 7, [Score=349, Expect=9e-104]} {Dmel: FBgn0039501, CG5987, [Score=235, Expect=5e-65]} {Celegans: WBGene00019230, ttll-11, Tubulin Tyrosine Ligase Like, [Score=157, Expect=9e-40]} {Smed: dd_Smed_v6_13600_0_1, dd_Smed_v6_13600_0_1, [Score=314, Expect=3e-91]} {RNA1310_17573} {RNA815_57268} |
76. | MligTC455_14483 | 140 | 2.92 | Mlig455_028240 | Neo: - Age: - Region-enriched R2: 6.203/0.04837 |
2.586 | 0.989 | - | 0.701 | 0.896 | - | - | Mlig455_028240 {REF} {Length: 728} {RNA1310_111517} {RNA815_9716} | |
77. | MligTC455_49334 | 86 | 1.78 | Mlig455_037751 | Neo: - Age: - |
2.585 | 0.974 | - | 0.717 | 0.894 | - | - | Mlig455_037751 {REF} {Length: 708} {RNA1509_25826} {RNA1310_47741} {RNA815_23874} | |
78. | MligTC455_44712 | 665 | 13.86 | Mlig455_017186 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.471 Region-specific R2: 4.141 Region-enriched R2: 3.536/0.00000 |
2.581 | 0.759 | - | 0.855 | 0.967 | - | - | Mlig455_017186 {REF} {Length: 1018} {RNA1509_34252} {RNA1310_54269.1} {RNA815_55074} | |
79. | MligTC455_19709 | 221 | 4.6 | Mlig455_010385 | Neo: - Age: - Region-enriched R2: 4.689/0.03280 |
2.579 | 0.989 | - | 0.708 | 0.882 | - | - | Mlig455_010385 {REF} {Length: 903} {Pfam: Pancreatic hormone peptide [PF00159.20, score=43.2]} {RNA1509_54211} {RNA1310_54505.2} {RNA815_29389} | |
80. | MligTC455_17051 | 22 | 0.46 | Mlig455_042552 | Neo: - Age: - |
GRIA4 | 2.578 | 0.984 | - | 0.714 | 0.880 | - | - | Mlig455_042552 {REF} {Length: 3307} {Pfam: Ligand-gated ion channel [PF00060.28, score=83.3]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=45.2]; Receptor family ligand binding region [PF01094.30, score=25.8]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=19.8]} {Human: ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=139, Expect=2e-33]} {Mouse: ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=139, Expect=3e-33]} {Dmel: FBgn0038837, CG3822, [Score=142, Expect=2e-34]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=109, Expect=2e-24]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=246, Expect=7e-74]} {RNA1310_33224} {RNA815_17044} |
81. | MligTC455_40290 | 58 | 1.21 | Mlig455_058728 | Neo: - Age: - Region-enriched R2: 4.464/0.00807 |
2.577 | 0.768 | - | 0.972 | 0.837 | - | - | Mlig455_058728 {REF} {Length: 1351} {Pfam: CUB domain [PF00431.22, score=48.4]} {RNA1310_48745} {RNA815_23305} | |
82. | MligTC455_50172 | 243 | 5.05 | Mlig455_067182 | Neo: - Age: Down-Up-Up Region-specific R2: 6.036 Region-enriched R2: 6.524/0.00000 |
2.577 | 0.774 | - | 0.841 | 0.962 | - | - | Mlig455_067182 {REF} {Length: 638} {Pfam: Pancreatic hormone peptide [PF00159.20, score=47.5]} {RNA1509_60030} {RNA1310_56761, RNA1509_60030} {RNA1509_60030, RNA815_31877.1} | |
83. | MligTC455_22323 | 68 | 1.42 | Mlig455_000713, Mlig455_000766 | Neo: - Age: - |
HCN4 | 2.564 | 0.819 | - | 0.967 | 0.778 | - | - | Mlig455_000713 {REF} {Length: 3555} {Pfam: Ion transport protein N-terminal [PF08412.12, score=83.6]; Cyclic nucleotide-binding domain [PF00027.31, score=70.8]; Ion transport protein [PF00520.33, score=62.7]} {Human: ENSG00000138622, HCN4, hyperpolarization activated cyclic nucleotide gated potassium channel 4, [Score=581, Expect=0.0]; ENSG00000099822, HCN2, hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, [Score=568, Expect=0.0]} {Mouse: ENSMUSG00000032338, Hcn4, hyperpolarization-activated, cyclic nucleotide-gated K+ 4, [Score=579, Expect=0.0]; ENSMUSG00000020331, Hcn2, hyperpolarization-activated, cyclic nucleotide-gated K+ 2, [Score=563, Expect=0.0]} {Dmel: FBgn0263397, Ih, I[[h]] channel, [RH, Score=512, Expect=1e-161]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=133, Expect=8e-32]} {Smed: dd_Smed_v6_16523_0_1, dd_Smed_v6_16523_0_1, [Score=859, Expect=0.0]} {RNA1509_59211} {RNA1310_33761} {RNA815_15561.1} Mlig455_000766 {REF} {Length: 4037} {Pfam: Ion transport protein N-terminal [PF08412.12, score=83.5]; Cyclic nucleotide-binding domain [PF00027.31, score=70.7]; Ion transport protein [PF00520.33, score=62.6]} {Human: ENSG00000138622, HCN4, hyperpolarization activated cyclic nucleotide gated potassium channel 4, [Score=566, Expect=0.0]; ENSG00000099822, HCN2, hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, [Score=553, Expect=0.0]} {Mouse: ENSMUSG00000032338, Hcn4, hyperpolarization-activated, cyclic nucleotide-gated K+ 4, [Score=564, Expect=0.0]; ENSMUSG00000020331, Hcn2, hyperpolarization-activated, cyclic nucleotide-gated K+ 2, [Score=548, Expect=3e-180]} {Dmel: FBgn0263397, Ih, I[[h]] channel, [Score=502, Expect=4e-166]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=133, Expect=8e-32]} {Smed: dd_Smed_v6_16523_0_1, dd_Smed_v6_16523_0_1, [Score=844, Expect=0.0]} {RNA1509_59211} {RNA1310_33761} {RNA815_15561.1} |
84. | MligTC455_43258 | 756 | 15.75 | Mlig455_027531 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=0.347 Region-enriched R2: 1.796/0.01868 Regeneration-downregulated BL: -3.121 Regeneration-depleted BL: -3.121 |
2.558 | 0.883 | - | 0.716 | 0.959 | - | - | Mlig455_027531 {REF} {Length: 695} {RNA1509_24629} {RNA1310_43299, RNA1509_24629} {RNA1509_24629, RNA815_28702} | |
85. | MligTC455_10151 | 146 | 3.05 | Mlig455_068692, Mlig455_068719 | Neo: - Age: - |
KREMEN1 | 2.556 | - | - | 0.982 | 0.844 | 0.730 | - | Mlig455_068692 {REF} {Length: 1086} {Pfam: WSC domain [PF01822.21, score=56.5]} {Human: ENSG00000183762, KREMEN1, kringle containing transmembrane protein 1, [Score=45.4, Expect=7e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=68.9, Expect=2e-14]} {RNA1310_42686} {RNA815_25047} Mlig455_068719 {REF} {Length: 1973} {TRANSSPLICED} {Pfam: WSC domain [PF01822.21, score=55.8]} {Human: ENSG00000183762, KREMEN1, kringle containing transmembrane protein 1, [Score=45.1, Expect=8e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=67.0, Expect=8e-14]} {RNA1509_56630} {RNA1310_42686} {RNA815_25047} |
86. | MligTC455_41824 | 194 | 4.03 | Mlig455_048229 | Neo: - Age: - Region-enriched R2: 3.040/0.03860 |
2.537 | - | - | 0.831 | 0.966 | - | 0.740 | Mlig455_048229 {REF} {Length: 769} {RNA1509_49797} {RNA1310_60350, RNA1509_49797} {RNA1509_49797, RNA815_30999} | |
87. | MligTC455_18833 | 771 | 16.06 | Mlig455_005836 | Neo: - Age: logFC(26M/2M)=-0.422 Region-enriched R2: 2.455/0.00029 |
2.531 | 0.840 | - | 0.952 | 0.739 | - | - | Mlig455_005836 {REF} {Length: 486} {RNA1509_25076} {RNA1310_75647, RNA1509_25076} {RNA1509_25076, RNA815_38932.1} | |
88. | MligTC455_26652 | 30 | 0.63 | Mlig455_036452 | Neo: - Age: - |
NR2E1 | 2.512 | 0.782 | - | 0.964 | 0.766 | - | - | Mlig455_036452 {REF} {Length: 2848} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=99.9]; Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=55.3]} {Human: ENSG00000112333, NR2E1, nuclear receptor subfamily 2 group E member 1, [Score=139, Expect=2e-35]} {Mouse: ENSMUSG00000019803, Nr2e1, nuclear receptor subfamily 2, group E, member 1, [Score=139, Expect=1e-35]} {Dmel: FBgn0015381, dsf, dissatisfaction, [Score=129, Expect=6e-31]} {Celegans: WBGene00021417, nhr-236, Nuclear Hormone Receptor family, [RH, Score=135, Expect=1e-35]} {Smed: dd_Smed_v6_25420_0_1, dd_Smed_v6_25420_0_1, [RH, Score=182, Expect=3e-50]} {RNA1310_57853} {RNA815_57699} |
89. | MligTC455_15837 | 58 | 1.21 | Mlig455_058574 | Neo: - Age: Up-Down-Up |
PLEKHG5 | 2.511 | 0.726 | - | 0.955 | 0.830 | - | - | Mlig455_058574 {REF} {Length: 3473} {Pfam: RhoGEF domain [PF00621.22, score=89.0]; Pleckstrin homology domain [PF15405.8, score=20.1]} {Human: ENSG00000171680, PLEKHG5, pleckstrin homology and RhoGEF domain containing G5, [Score=191, Expect=1e-49]} {Mouse: ENSMUSG00000039713, Plekhg5, pleckstrin homology domain containing, family G (with RhoGef domain) member 5, [Score=194, Expect=1e-50]} {Dmel: FBgn0261556, CG42674, [Score=147, Expect=1e-35]} {Celegans: WBGene00006476, rhgf-2, RHGF-2; RHo Guanine nucleotide exchange Factor, [RH, Score=142, Expect=3e-34]} {Smed: dd_Smed_v6_10072_0_1, dd_Smed_v6_10072_0_1, [Score=171, Expect=2e-44]} {RNA1310_47096} {RNA815_12538} |
90. | MligTC455_53333 | 44 | 0.91 | Mlig455_019019, Mlig455_055684 | Neo: - Age: Up-Down-Up Region-enriched R4: 4.725/0.03950 |
CHRNA7 | 2.509 | 0.750 | - | 0.794 | 0.965 | - | - | Mlig455_019019 {REF} {Length: 2615} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=154.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=93.9]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=210, Expect=2e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=208, Expect=5e-59]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=207, Expect=8e-59]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=206, Expect=3e-58]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=209, Expect=1e-59]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=205, Expect=3e-58]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=221, Expect=3e-63]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=190, Expect=7e-53]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [Score=426, Expect=5e-142]} {RNA1509_56207} {RNA1310_26355} {RNA815_26644} Mlig455_055684 {REF} {Length: 2604} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=154.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=94.7]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=211, Expect=9e-60]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=209, Expect=3e-59]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=208, Expect=5e-59]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=207, Expect=7e-59]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=209, Expect=9e-60]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=204, Expect=1e-57]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=222, Expect=1e-63]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=190, Expect=6e-53]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [Score=427, Expect=3e-142]} {RNA1509_56207} {RNA1310_26355} {RNA815_26644} |
91. | MligTC455_49491 | 136 | 2.83 | Mlig455_054796 | Neo: - Age: - Region-enriched R2: 7.065/0.00003 |
2.492 | 0.713 | - | 0.996 | 0.783 | - | - | Mlig455_054796 {REF} {Length: 1567} {RNA1509_22234} {RNA1310_23973} {RNA815_10832} | |
92. | MligTC455_16209 | 72 | 1.51 | Mlig455_020329 | Neo: - Age: - Region-enriched R2: 5.444/0.00658 |
2.388 | 0.971 | - | 0.710 | 0.707 | - | - | Mlig455_020329 {REF} {Length: 2483} {Pfam: TIR domain [PF13676.8, score=38.4]; TIR domain [PF01582.22, score=29.5]; Domain of unknown function (DUF4481) [PF14800.8, score=20.4]} {Dmel: FBgn0032095, Toll-4, [RH, Score=53.1, Expect=7e-07]} {Smed: dd_Smed_v6_14454_0_1, dd_Smed_v6_14454_0_1, [RH, Score=270, Expect=2e-82]} {RNA1310_32445} {RNA815_27719} | |
93. | MligTC455_52570 | 71 | 1.49 | Mlig455_066071 | Neo: - Age: Up-Down-Up |
1.987 | 0.989 | - | 0.998 | - | - | - | Mlig455_066071 {REF} {Length: 2575} {Pfam: Hemingway/CFA97 [PF13879.8, score=54.6]; Annexin [PF00191.22, score=26.1]} {Mouse: ENSMUSG00000090336, Cfap97d2, CFAP97 domain containing 2, [Score=46.6, Expect=3e-06]} {Smed: dd_Smed_v6_2676_0_1, dd_Smed_v6_2676_0_1, [Score=70.1, Expect=2e-13]} {RNA1310_29320.1} {RNA815_54680} | |
94. | MligTC455_52640 | 56 | 1.18 | Mlig455_045103 | Neo: - Age: - Region-enriched R2: 6.488/0.02940 |
1.985 | 0.998 | - | 0.987 | - | - | - | Mlig455_045103 {REF} {Length: 2443} {Pfam: F5/8 type C domain [PF00754.27, score=19.1]} {RNA1509_57504} {RNA1310_27303.2} {RNA815_32964} | |
95. | MligTC455_15974 | 179 | 3.73 | Mlig455_046153, Mlig455_046238 | Neo: - Age: - Region-enriched R2: 9.367/0.02495 |
1.983 | 0.989 | - | 0.994 | - | - | - | Mlig455_046153 {REF} {Length: 345} {Pfam: Pancreatic hormone peptide [PF00159.20, score=36.0]} {RNA1310_79109} {RNA815_46493} Mlig455_046238 {REF} {Length: 211} {NoTransDecoderORF} {RNA1310_79109} {RNA815_46493} |
|
96. | MligTC455_38950 | 23 | 0.47 | Mlig455_065213 | Neo: - Age: - |
1.98 | 0.989 | - | 0.991 | - | - | - | Mlig455_065213 {REF} {Length: 567} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=23.2]} {RNA1509_44618} {RNA1310_63839} {RNA815_35329} | |
97. | MligTC455_32025 | 18 | 0.36 | Mlig455_028181, Mlig455_028252 | Neo: - |
1.972 | 0.972 | - | 1.000 | - | - | - | Mlig455_028181 {REF} {Length: 4403} {Pfam: PH domain [PF00169.31, score=19.7]} {RNA1310_106355} Mlig455_028252 {REF} {Length: 3659} {Pfam: PH domain [PF00169.31, score=20.0]} {RNA1310_106355} |
|
98. | MligTC455_09456 | 47 | 0.97 | Mlig455_029993 | Neo: - Age: - Region-enriched R2: 5.041/0.00960 |
1.966 | 0.972 | - | 0.994 | - | - | - | Mlig455_029993 {REF} {Length: 3167} {RNA1509_44134} {RNA1310_31411} {RNA815_45870} | |
99. | MligTC455_40707 | 15 | 0.31 | Mlig455_033559, Mlig455_067009 | Neo: - Age: - |
GRIK2 | 1.966 | 0.982 | - | 0.984 | - | - | - | Mlig455_033559 {REF} {Length: 3723} {tRNA: Val(CAC),pseudo, score=30.0} {Pfam: Ligand-gated ion channel [PF00060.28, score=144.7]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=101.2]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=66.3]; Receptor family ligand binding region [PF01094.30, score=22.9]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=325, Expect=4e-97]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=318, Expect=2e-94]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=309, Expect=8e-91]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=323, Expect=2e-96]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=316, Expect=2e-93]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=310, Expect=3e-92]} {Dmel: FBgn0038837, CG3822, [Score=292, Expect=2e-85]} {Celegans: WBGene00001613, glr-2, Glutamate receptor 2, [Score=252, Expect=8e-71]} {Smed: dd_Smed_v6_14655_0_1, dd_Smed_v6_14655_0_1, [Score=357, Expect=2e-108]} {RNA1310_11982.1} {RNA815_20096} Mlig455_067009 {REF} {Length: 2583} {Pfam: Ligand-gated ion channel [PF00060.28, score=121.5]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=101.3]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=46.3]; Receptor family ligand binding region [PF01094.30, score=22.3]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=267, Expect=1e-76]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=265, Expect=2e-75]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=260, Expect=7e-74]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=267, Expect=1e-76]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=262, Expect=1e-74]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=259, Expect=2e-74]} {Dmel: FBgn0038837, CG3822, [Score=234, Expect=2e-65]} {Celegans: WBGene00001613, glr-2, Glutamate receptor 2, [Score=208, Expect=2e-56]} {Smed: dd_Smed_v6_14655_0_1, dd_Smed_v6_14655_0_1, [Score=281, Expect=2e-81]} {RNA1310_11982.1} {RNA815_20096} |
100. | MligTC455_52480 | 25 | 0.51 | Mlig455_040937 | Neo: - Age: - |
1.965 | - | - | 0.982 | 0.983 | - | - | Mlig455_040937 {REF} {Length: 2050} {RNA1310_86606} {RNA815_50003.1} |